Aptamers targeting SARS-COV-2: a promising tool to fight against COVID-19

SARS-CoV-2, the causative agent of COVID-19, remains among the main causes of global mortality. Although antigen/antibody-based immunoassays and neutralizing antibodies targeting SARS-CoV-2 have been successfully developed over the past 2 years, they are often inefficient and unreliable for emerging...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yang, Juhas, Mario, Kwok, Chun Kit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9340053/
https://www.ncbi.nlm.nih.gov/pubmed/35995601
http://dx.doi.org/10.1016/j.tibtech.2022.07.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9340053/
https://www.ncbi.nlm.nih.gov/pubmed/35995601
http://dx.doi.org/10.1016/j.tibtech.2022.07.012

Ejemplares similares